Advances in Research into Reperfusion Injury in Patients with Acute Myocardial Infarction

CHEN Yu-guo,SUN Yi,ZHANG Yun

DOI: https://doi.org/10.3969/j.issn.1004-3934.2006.05.030

2006-01-01

Abstract:Acute myocardial infarction is a major global cause of death.Reperfusion is essential for the survival of ischemic myocardium.However,reperfusion itself may lead to accelerated and additional myocardial injury beyond that generated by ischemia alone.

What problem does this paper attempt to address?

Important Issues and Relative Approaches in Myocardial Ischemic Reperfusion

LU Dian-xiang,WU Hai-ying,LU Dian-rong,LONG Qi-fu,ZHANG Shu-na,JIA Ying,WANG Xin-pei,GE Ri-li

DOI: https://doi.org/10.3969/j.issn.1005-9903.2011.12.074

2011-01-01

Abstract:Objective:To discuss some unresolved problems in myocardial ischemia/reperfusion research and to review some approaches for successfully combining adjuvant therapies with coronary artery opening.Method:The researches in myocardial ischemia/reperfusion in recent years were reviewed.Result:Reperfusion can produce significant salvage of ischemic myocardium.According to reports,the operation was carried out in 60-90 min for effective reperfusion and optimal myocardial salvage which conveys decreased short-term and long-term mortality compared with longer ischemic times.Reperfusion has negative effects on ischemic myocardium,which collectively are referred to as myocardial reperfusion injury,which complicates with arrhythmias,microcirculatory disturbances and progression to cell death of critically injured cardiomyocytes.Progressive unregulated remodeling is the important mortality in acute myocardial infarction.The development of clinical care systems that can routinely deliver very timely coronary opening and reperfusion,the limitation of myocardial reperfusion injury,the strategies to retard adverse remodeling are the difficult issues in reperfusion.Promising approaches are being explored including pre-conditioning and post-conditioning,activators of the reperfusion injury salvage kinase pathway and stem cell therapy.Conclusion:Myocardial reperfusion after ischemia is a double-bladed sword:the advantages mixed up with the problems.These challenges could be overcome by combining adjuvant therapies with reperfusion.
Research Progress on the Mechanism and Treatment of Inflammatory Response in Myocardial Ischemia-Reperfusion Injury

Dong Zhang,Hui Wu,Di Liu,Yun Zhao Li,Gang Zhou

DOI: https://doi.org/10.1532/hsf.4725

2022-01-01

Abstract:Acute myocardial infarction can be treated aggressively with intravenous thrombolysis, percutaneous coronary intervention, and coronary artery bypass grafting; however, recanalization can cause myocardial ischemia-reperfusion injury (MIRI). This is an important reason that restricts the treatment effect of patients. After the ischemic myocardium is restored to perfusion, an inflammatory response can occur within minutes and peak within a few days. Many pro -inflam-matory cytokines can seriously damage cardiac function. Inflammation can regulate cardiomyocyte apoptosis, autoph-agy, pyroptosis, and necrosis, and is the main initiating factor leading to MIRI in cardiomyocytes. This article reviews the mechanism of inflammatory response in the ischemia-reperfusion period after acute myo-cardial infarction and the clinical value and application pros-pect of inhibiting inflammatory response in the treatment of acute myocardial infarction.
Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection

Nan-Bo Liu,Min Wu,Chen Chen,Masayuki Fujino,Jing-Song Huang,Ping Zhu,Xiao-Kang Li

DOI: https://doi.org/10.1155/2019/6935147

IF: 1.99

2019-05-28

Cardiology Research and Practice

Abstract:Worldwide morbidity and mortality from acute myocardial infarction (AMI) and related heart failure remain high. While effective early reperfusion of the criminal coronary artery after a confirmed AMI is the typical treatment at present, collateral myocardial ischemia-reperfusion injury (MIRI) and pertinent cardioprotection are still challenging to address and have inadequately understood mechanisms. Therefore, unveiling the related novel molecular targets and networks participating in triggering and resisting the pathobiology of MIRI is a promising and valuable frontier. The present study specifically focuses on the recent MIRI advances that are supported by sophisticated bio-methodology in order to bring the poorly understood interrelationship among pro- and anti-MIRI participant molecules up to date, as well as to identify findings that may facilitate the further investigation of novel targets.

cardiac & cardiovascular systems
Antioxidants in the prevention of myocardial ischemia/reperfusion injury

Chengxue Qin,Suwan Yap,Owen L Woodman

DOI: https://doi.org/10.1586/ecp.09.41

Abstract:In acute myocardial ischemia (AMI) the optimal treatment is rapid revascularization by angioplasty or pharmacological thrombolysis. While this is essential to resuscitate the ischemic myocardium, it results in further reperfusion injury and extension of the infarction. The main hypothesis for the mechanism of reperfusion injury is the generation of reactive oxygen species (ROS) to such a degree that endogenous antioxidant mechanisms are overcome and tissue injury results. There is growing evidence that ROS-induced injury may continue for weeks to months as a result of activation of apoptosis. In the longer term, this may result in ventricular remodeling and cardiac failure. Although a number of antioxidants have produced beneficial effects in animal models of AMI, none have proved efficacious in subsequent clinical trials. Drugs that are more specific for the source of ROS generation and that are better able to target the sources of oxidant stress may have greater potential for the prevention of reperfusion injury.
Research progress of reperfusion injury salvage kinase and survivor activating factor enhancement signal pathway in myocardial ischemia reperfusion injury

Zong-Mei ZHENG,Ming-Ming ZHU,Yu-Jun SHEN,Ning SU,Fen-Ping LU,Xiang LI,Hong-Fei SHI

DOI: https://doi.org/10.3969/j.issn.1007-3949.2017.11.018

2017-01-01

Abstract:Percutaneous coronary intervention and thrombolytic therapy can significantly benefit and improve the prognosis of myocardial infarction patients,but the following problem of myocardial ischemia reperfusion injury is also prominent.Myocardial ischemia reperfusion injury involves multiple target pathways,and the relationship between different signaling pathways is complex.In recent years,reperfusion injury salvage kinase and survivor activating factor enhancement,two novel survival promoting kinase signaling pathways,have emerged as a new target for the treatment of reperfusion intervention,thus becoming a new breakthrough point in cardiovascular diseases and even other vascular diseases.This article aims to explain the mechanism of the protective effects of these two signaling pathways on myocardial ischemia reperfusion,and provide a new approach for the research and development of new dhugs for myocardial infarction.
Cardioprotective Strategies after Ischemia–Reperfusion Injury

Honghong Zhang,Huilin Hu,Changlin Zhai,Lele Jing,Hongen Tian

DOI: https://doi.org/10.1007/s40256-023-00614-4

2023-01-01

Abstract:Acute myocardial infarction (AMI) is associated with high morbidity and mortality worldwide. Although early reperfusion is the most effective strategy to salvage ischemic myocardium, reperfusion injury can develop with the restoration of blood flow. Therefore, it is important to identify protection mechanisms and strategies for the heart after myocardial infarction. Recent studies have shown that multiple intracellular molecules and signaling pathways are involved in cardioprotection. Meanwhile, device-based cardioprotective modalities such as cardiac left ventricular unloading, hypothermia, coronary sinus intervention, supersaturated oxygen (SSO2), and remote ischemic conditioning (RIC) have become important areas of research. Herein, we review the molecular mechanisms of cardioprotection and cardioprotective modalities after ischemia-reperfusion injury (IRI) to identify potential approaches to reduce mortality and improve prognosis in patients with AMI.
Advances in Research on Mechanisms of Myocardial Ischemia-reperfusion Injury and Related Therapeutic Drugs

吴烨,何玲

DOI: https://doi.org/10.3969/j.issn.1001-5094.2010.07.003

2010-01-01

Abstract:Myocardial ischemia-reperfusion injury (MIRI) often occurs when the blood flow is reco-vered based on myocardial ischemia.It may cause aggravation of tissue injury,which is sometimes even irreversible.MIRI has become a hot issue,which is concerned by more and more researchers.The advances in researches on mechanisms of MIRI were reviewed,and some relevant therapeutic drugs were introduced in this paper,so as to provide references and thoughts for the further recognizing of the MIRI mechanisms and relevant drugs development.
Coronary Microvascular Reperfusion Injury and No-Reflow in Acute Myocardial Infarction

Sheng Kang,Yuejin Yang

DOI: https://doi.org/10.25011/cim.v30i3.1082

2007-01-01

Abstract:To review (1) the mechanisms of coronary microvascular reperfusion injury, particularly in the relationships between microvascular endothelium dysfunction, microstructure damage, microemboli and no-reflow phenomena; (2) the no-reflow presentation and management at ischemia-reperfusion to suggest future direction for no-reflow therapy in acute myocardial infarction.Original articles and reviews published between 1997 and 2007 and focusing on the no-reflow phenomenon in MEDLINE and PubMed. The search terms used were "no-reflow", "microvascular injury", "acute myocardial infarction" and "reperfusion injury". All papers identified were English-language, full text papers. In addition, the reference lists of identified relevant articles were also searched.The no-reflow phenomenon is characterised by damage to microvascular function and microstructure at ischaemia-reperfusion. Microemboli contribute to no-reflow. Clinical myocardial contrast echocardiography (MCE), scintigraphic and magnetic resonance imaging (MRI) have shown evidence of microvascular damage, eg, perfusion defects are closely related to lack of contractile recovery and irreversible myocyte damage. Clinical agents and devices targeting microvascular injury (especially protection of endothelium and reduction of microemboli) after acute myocardial infarction may be key points to improve no-reflow.
A Bibliometric Analysis of 14,822 Researches on Myocardial Reperfusion Injury by Machine Learning

Chan Li,Zhaoya Liu,Ruizheng Shi

DOI: https://doi.org/10.3390/ijerph18158231

2021-01-01

Abstract:Myocardial ischemia is the major cause of death worldwide, and reperfusion is the standard intervention for myocardial ischemia. However, reperfusion may cause additional damage, known as myocardial reperfusion injury, for which there is still no effective therapy. This study aims to analyze the landscape of researches concerning myocardial reperfusion injury over the past three decades by machine learning. PubMed was searched for publications from 1990 to 2020 indexed under the Medical Subject Headings (MeSH) term “myocardial reperfusion injury” on 13 April 2021. MeSH analysis and Latent Dirichlet allocation (LDA) analyses were applied to reveal research hotspots. In total, 14,822 publications were collected and analyzed in this study. MeSH analyses revealed that time factors and apoptosis were the leading terms of the pathogenesis and treatment of myocardial reperfusion injury, respectively. In LDA analyses, research topics were classified into three clusters. Complex correlations were observed between topics of different clusters, and the prognosis is the most concerned field of the researchers. In conclusion, the number of publications on myocardial reperfusion injury increases during the past three decades, which mainly focused on prognosis, mechanism, and treatment. Prognosis is the most concerned field, whereas studies on mechanism and treatment are relatively lacking.
Cardioprotection Against Reperfusion Injury: Updated Mechanisms and Strategies.

Jin-Kun Xi,Yuan-Zhe Jin,Xun Cui,Zhelong Xu

DOI: https://doi.org/10.3321/j.issn:0371-0874.2007.05.003

2007-01-01

Abstract:Early restoration of blood flow to the ischemic myocardium not only saves myocardium but also induces reperfusion injury. While no specific therapy to reduce reperfusion injury has yet been established, recent laboratory studies have shown that G protein-coupled receptor (GPCR) agonists, insulin, and postconditioning can effectively prevent reperfusion injury in various experimental settings and animal species. The potential mechanisms underlying the cardioprotection initiated by these interventions may include activation of the reperfusion injury salvage kinase (RISK) pathway, inactivation of glycogen synthase kinase 3beta (GSK-3beta), and modulation of mitochondrial permeability transition pore (mPTP) opening. These encouraging laboratory findings may help us develop successful clinical strategies to salvage reperfused myocardium in patients with acute myocardial infarction.
Recent Advance on Drug Therapy Related to Myocardial Ischemia Reperfusion Injury

Yuezhu Liu,Hua Zeng,Junmei Xu

DOI: https://doi.org/10.1166/jbt.2022.2899

2022-02-01

Journal of Biomaterials and Tissue Engineering

Abstract:Myocardial ischemia reperfusion injury (MIRI) means complete or partial artery obstruction of coronary artery, and ischemic myocardium will be recirculating in a period of time. Although the ischemic myocardium can be restored to normal perfusion, its tissue damage will instead be progressive. An aggravated pathological process. MIRI is a complex entity where many inflammatory mediators play different roles, both to enhance myocardial infarction-derived damage and to heal injury. Therefore, the research and development of drugs for the prevention and treatment of this period has also become the focus. This article first studied pathophysiology of MIRI, and reviewed the research progress of MIRI-related drugs. Research results show that: MIRI is inevitable for myocardial ischemia, with the possible to double damage via the ischemic condition. Therefore, it is a serious complication and one of the most popular diseases in the world. It has always been difficult to find an effective treatment for this disease, because it is difficult to explore the inflammation behind its pathophysiology.

cell & tissue engineering
Characterization of Early Myocardial Inflammation in Ischemia-Reperfusion Injury

Qihong Wu,Rong Xu,Kun Zhang,Ran Sun,Mengxi Yang,Kuan Li,Hanrui Liu,Yiyuan Xue,Huayan Xu,Yingkun Guo

DOI: https://doi.org/10.3389/fimmu.2022.1081719

IF: 7.3

2023-01-01

Frontiers in Immunology

Abstract:BackgroundMyocardial injury may be caused by myocardial ischemia-reperfusion (IR), and salvaging such an injury is still a great challenge in clinical practice. This study comprehensively characterized the physiopathologic changes of myocardial injury after IR to explore the underlying mechanism in the early reperfusion phase with particular emphasis on early myocardial inflammation. Methods and ResultsThe experimental IR model was obtained by the left anterior descending artery's transient ligation of C57BL/6 mice. T2W signals of all mice showed increased signal at different IR stages. It was positively correlated with inflammatory cytokines and cells. T2W imaging by 7.0 T MRI surprisingly detected signal enhancement, but histopathology and flow cytometry did not reveal any inflammatory cells infiltration within 3 h after IR. Cardiomyocyte swelling and increased vascular permeability were observed by WGA staining and ultrastructural analysis, respectively. The 3 h IR group showed that the cardiomyocytes were severely affected with disintegrating myofilaments and mitochondria. Both VEGF and phosphorylated Src protein were markedly expressed in the 3 h IR group in comparison with the sham group, and TUNEL staining displayed little positive cells. Cleaved caspase-3 apoptin also has similar expression levels with that of the sham group. Resident macrophages had notably become M1 phenotype. The T2W signal was still elevated, and we observed that collagen deposition occurred from 1 to 7 days. ConclusionsThe inflammation response during the first week after reperfusion injury gradually increase 3 h later, but the main manifestation before that was edema. This study indicated that the first 3 h may be crucial to the early rescue process for reperfusion-induced myocardial injury due to inflammatory cell infiltration absence and apoptosis.
Modern Knowledge of Myocardial No-Reflow

陈玉国,徐峰,张运

DOI: https://doi.org/10.3969/j.issn.1004-3934.2004.05.003

2004-01-01

Abstract:Recently, many achievements have been acquired in the researches of myocardial no-reflow,and more and more results of researches suggest that myocardial no-reflow phenomenon has close relation to the prognosis of acute myocardial infarction (AMI).It is important to decrease and even prevent the phenomenon during clinical treatment of AMI.We will summarize the modern knowledge of the phenomenon in this article.
A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023

Yifei Wang,Lijun Guo,Zhibo Zhang,Shuangqing Fu,Pingping Huang,Anzhu Wang,Mi Liu,Xiaochang Ma

DOI: https://doi.org/10.3389/fcvm.2023.1180792

IF: 3.6

2023-06-14

Frontiers in Cardiovascular Medicine

Abstract:Background: Myocardial ischemia/reperfusion injury (MIRI) refers to the more severe damage that occurs in the previously ischemic myocardium after a short-term interruption of myocardial blood supply followed by restoration of blood flow within a certain period of time. MIRI has become a major challenge affecting the therapeutic efficacy of cardiovascular surgery. Methods: A scientific literature search on MIRI-related papers published from 2000 to 2023 in the Web of Science Core Collection database was conducted. VOSviewer was used for bibliometric analysis to understand the scientific development and research hotspots in this field. Results: A total of 5,595 papers from 81 countries/regions, 3,840 research institutions, and 26,202 authors were included. China published the most papers, but the United States had the most significant influence. Harvard University was the leading research institution, and influential authors included Lefer David J., Hausenloy Derek J., Yellon Derek M., and others. All keywords can be divided into four different directions: risk factors, poor prognosis, mechanisms and cardioprotection. Conclusion: Research on MIRI is flourishing. It is necessary to conduct an in-depth investigation of the interaction between different mechanisms and multi-target therapy will be the focus and hotspot of MIRI research in the future.

cardiac & cardiovascular systems
MG53 Protein: A Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury

Xiaoya Zhou,Mingxian Chen,Songyun Wang,Lilei Yu,Hong Jiang

DOI: https://doi.org/10.1016/j.ijcard.2015.07.084

IF: 4.039

2015-01-01

International Journal of Cardiology

Abstract:Acute myocardial ischemia is the leading cause of morbidity and mortality worldwide [ 1 Zhou X. Sheng X. Chen M. Wang Z. Yu L. Jiang H. Tumor necrosis factor-α inhibitor: a promising therapeutic approach for attenuating myocardial ischemia–reperfusion by antioxidant stress. Int. J. Cardiol. 2015; 190: 282-283 Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar , 2 Lee S.M. Hutchinson M. Staikopoulos V. Saint D.A. Amitriptyline pharmacologically preconditions rat hearts against cardiac ischemic–reperfusion injury. Int. J. Cardiol. 2015; 190: 353-359 Abstract Full Text Full Text PDF PubMed Scopus (9) Google Scholar ]. Although abrupt restoration of coronary blood flow would rescue ischemic myocardium, reduce infarct size, attenuate cardiac remodeling and improve systolic function, the additional cardiomyocyte damage and myocardial fibrosis usually could not be evitable [ [3] Chen M. Yu L. Liu Q. Jiang H. Zhou S. Interleukin-17 inhibition: an important target for attenuating myocardial ischemia and reperfusion injury. Int. J. Cardiol. 2015; 198: 89-90 Abstract Full Text Full Text PDF PubMed Scopus (6) Google Scholar ]. This damage is defined as myocardial ischemic reperfusion injury (MIRI). Currently, there is still a lack of effective strategies for attenuating MIRI. Therefore, alternative favorable treatment is urgently needed to reduce cardiomyocyte loss and minimize myocardial fibrosis.
[Reperfusion Arrhythmias in Acute Myocardial Infarction Do Not Enhance Myocardial Injury].

Yi Luo,Guang-lian Li,Yi-zhi Pan,Chong Zeng,Xiao-ming Lei,Zhen Liu,Kai-Wei Feng,Yao-qiu Pi,Lei Lü

DOI: https://doi.org/10.3760/j:issn:0253-3758.2007.02.016

2007-01-01

Abstract:OBJECTIVE:To investigate the clinical implications of reperfusion arrhythmias during primary percutaneous coronary intervention (PCI) for patients with acute myocardial infarction (AMI).METHODS:Data from 228 AMI patients in whom the infarct-related artery (IRA) were successfully recanalized by primary PCI were retrospectively analyzed. The 228 patients were divided into 2 groups: myocardial ischemia-reperfusion injury (MIRI) group (n=119) in whom MIRI events occurred within minutes after successful recanalization of IRA, and non-MIRI group (n=109). The 119 patients in MIRI group were further divided into 3 subgroups: severe bradycardia with hypotension (brady-arrhythmia subgroup), lethal ventricular arrhythmias requiring electrical cardioversion (tachy-arrhythmia subgroup), and IRA antegrade flow less than or equal to TIMI 2 grade without angiographic evidence of abrupt closure (no-reflow subgroup).RESULTS:(1) Clinical and angiographic data: Compared with non-MIRI group, MIRI group was characterized by more inferior infarct location, shorter ischemic duration, more frequently right coronary artery as IRA, more diseased vessels, more often TIMI 0 grade of initial antegrade flow in IRA, less pre-infarction angina, more renal insufficiency, and higher in-hospital mortality (13.4% vs. 4.6%, P=0.021). (2) The peak CK level was remarkably lower in brady-arrhythmia subgroup than that in non-MIRI group (2010 IU/L vs. 2521 IU/L, P=0.039). The peak CK or CK-MB level was notably higher in no-reflow subgroup than in non-MIRI group (4573 IU/L, 338 IU/L, respectively, P=0.000). (3) Left ventricular ejection fraction in no-reflow subgroup was significantly lower than in non-MIRI group (38.7% +/- 8.3% vs. 51.2% +/- 8.1%, P=0.000), left ventricular end-diastolic volume in no-reflow subgroup was greater than that in tachy-arrhythmia subgroup [(135 +/- 32) ml vs. (105 +/- 19) ml, P=0.029].CONCLUSION:Reperfusion arrhythmias may imply the existence of much survived myocardium and do not enhance myocardial damage, while no-reflow increases myocardial injury and induces permanent impairment of cardiac function.
Tumor Necrosis Factor-Α Inhibitor: A Promising Therapeutic Approach for Attenuating Myocardial Ischemia–reperfusion by Antioxidant Stress

Xin Zhou,Xia Sheng,Mingxian Chen,Zhuo Wang,Lilei Yu,Hong Jiang

DOI: https://doi.org/10.1016/j.ijcard.2015.04.194

IF: 4.039

2015-01-01

International Journal of Cardiology

Abstract:Acute myocardial infarction (AMI) is one of the most common cardiovascular diseases with a leading cause of death worldwide [ [1] Wang J. Li L. Jiang H. c-Cbl inhibition: a novel therapeutic approach for attenuating myocardial ischemia and reperfusion injury. Int. J. Cardiol. 2015; 186: 50-51 Abstract Full Text Full Text PDF PubMed Scopus (4) Google Scholar ]. Although strategies such as drug thrombolysis or percutaneous coronary intervention (PCI) are currently considered to be the most effective therapy for rescuing ischemic myocardium, reducing infarct size and improving left ventricular dysfunction, the following abrupt reperfusion for ischemic myocardial tissues may inevitably result in additional damage in the early period [ 2 Xiang F.L. Lu X. Liu Y. Feng Q. Cardiomyocyte-specific overexpression of human stem cell factor protects against myocardial ischemia and reperfusion injury. Int. J. Cardiol. 2013; 168: 3486-3494 Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar , 3 Yellon D.M. Hausenloy D.J. Myocardial reperfusion injury. N. Engl. J. Med. 2007; 357: 1121-1135 Crossref PubMed Scopus (3013) Google Scholar ]. This phenomenon, so-called myocardial ischemia–reperfusion injury (MIRI), is a complex progression including reactive oxygen species (ROS) overproduction, mitochondrial dysfunction and induction of autophagy dysfunction [ 4 Wang Z. Wang Y. Ye J. Lu X. Cheng Y. Xiang L. et al. bFGF attenuates endoplasmic reticulum stress and mitochondrial injury on myocardial ischaemia/reperfusion via activation of PI3K/Akt/ERK1/2 pathway. J. Cell. Mol. Med. 2015; 19: 595-607 Crossref PubMed Scopus (82) Google Scholar , 5 Zhou L. Sung R.Y. Li K. Pong N.H. Xiang P. Shen J. Cardioprotective effect of dexrazoxane in a rat model of myocardial infarction: anti-apoptosis and promoting angiogenesis. Int. J. Cardiol. 2011; 152: 196-201 Abstract Full Text Full Text PDF PubMed Scopus (17) Google Scholar ]. Currently, effective therapy to reduce reperfusion damage is still lacking. Thus, alleviating MIRI may become urgently needed.
A Bibliometric Study Related to the Treatment of Myocardial Ischemia-Reperfusion Injury

Jie Feng,Leilei Han,Yunman Liu,Kai Li,Yanqing Wu

DOI: https://doi.org/10.1186/s13019-024-02924-3

2024-01-01

Journal of Cardiothoracic Surgery

Abstract:Myocardial ischemia-reperfusion injury (MIRI) is defined as the restoration of blood flow to the myocardium after a brief interruption of blood supply, causing more severe damage to the ischemic myocardium. However, currently, reperfusion therapy is the preferred therapy for ischemic cardiomyopathy, which undoubtedly causes MIRI, and thus it has become a challenging issue affecting the prognosis of coronary artery disease. A search was conducted in the Web of Science Core Collection database for papers relevant to MIRI therapy published between 1 January 2000 and 1 October 2023. Bibliometric analyses were performed using VOSviewer and CiteSpace to elucidate the progress and hotspots. 3304 papers from 64 countries, 2134 research institutions and 13,228 authors were enrolled in the study. Of these, China contributed the most papers and had the biggest impact, while the United States had the most extensive partnership. The Fourth Military Medical University was the primary research institution. The most valuable authors include Chattipakorn, Nipon, Chattipakorn, Siriporn c, Yang, Jian and Yang, Yang. Over the past 20 years, research on MIRI therapies has made significant strides. Further studies are necessary to explore the interactions between various therapeutic options. Future investigations will emphasize nanocarriers, cardiac regeneration, and stem cell therapies. Our study identifies MIRI research hotspots from a bibliometric perspective, forecasts future trends, and offers fresh insights into MIRI therapy research.
Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review)

Jianfeng He,Danyong Liu,Lixia Zhao,Dongcheng Zhou,Jianhui Rong,Liangqing Zhang,Zhengyuan Xia

DOI: https://doi.org/10.3892/etm.2022.11357

Abstract:Myocardial infarction is one of the primary causes of mortality in patients with coronary heart disease worldwide. Early treatment of acute myocardial infarction restores blood supply of ischemic myocardium and decreases the mortality risk. However, when the interrupted myocardial blood supply is recovered within a certain period of time, it causes more serious damage to the original ischemic myocardium; this is known as myocardial ischemia/reperfusion injury (MIRI). The pathophysiological mechanisms leading to MIRI are associated with oxidative stress, intracellular calcium overload, energy metabolism disorder, apoptosis, endoplasmic reticulum stress, autophagy, pyroptosis, necroptosis and ferroptosis. These interplay with one another and directly or indirectly lead to aggravation of the effect. In the past, apoptosis and autophagy have attracted more attention but necroptosis and ferroptosis also serve key roles. However, the mechanism of MIRI has not been fully elucidated. The present study reviews the mechanisms underlying MIRI. Based on current understanding of the pathophysiological mechanisms of MIRI, the association between cell death-associated signaling pathways were elaborated, providing direction for investigation of novel targets in clinical treatment.
Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury

Chiu-Fen Yang

DOI: https://doi.org/10.4103/tcmj.tcmj_33_18

2018-01-01

Tzu Chi Medical Journal

Abstract:Acute myocardial ischemia/reperfusion (I/R) injury is a significant, unsolved clinical puzzle. In the disease context of acute myocardial infarction, reperfusion remains the only effective strategy to salvage ischemic myocardium, but it also causes additional damage. Myocardial I/R injury is composed of four types of damage, and these events attenuate the benefits of reperfusion therapy. Thus, inventing new strategies to conquer I/R injury is an unmet clinical need. A variety of pathological processes and mediators, including changes in the pH, generation of reactive oxygen radicals, and intracellular calcium overload, are proposed to be crucial in I/R-related cell injury. Among the intracellular events that occur during I/R, we stress the importance of protein phosphorylation signaling and elaborate its regulation. A variety of protein kinase pathways could be activated in I/R, including reperfusion injury salvage kinase and survivor-activating factor enhancement pathways, which are critical to cardiomyocyte survival. In addition to serine/threonine phosphorylation signaling, protein tyrosine phosphorylation is also critical in multiple cell functions and survival. However, the roles of protein kinases and phosphatases in I/R have not been extensively studied yet. By better understanding the mechanisms of I/R injury, we may have a better chance to develop new strategies for I/R injury and apply them in the clinical patient care.

Advances in Research into Reperfusion Injury in Patients with Acute Myocardial Infarction

Important Issues and Relative Approaches in Myocardial Ischemic Reperfusion

Research Progress on the Mechanism and Treatment of Inflammatory Response in Myocardial Ischemia-Reperfusion Injury

Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection

Antioxidants in the prevention of myocardial ischemia/reperfusion injury

Research progress of reperfusion injury salvage kinase and survivor activating factor enhancement signal pathway in myocardial ischemia reperfusion injury

Cardioprotective Strategies after Ischemia–Reperfusion Injury

Advances in Research on Mechanisms of Myocardial Ischemia-reperfusion Injury and Related Therapeutic Drugs

Coronary Microvascular Reperfusion Injury and No-Reflow in Acute Myocardial Infarction

A Bibliometric Analysis of 14,822 Researches on Myocardial Reperfusion Injury by Machine Learning

Cardioprotection Against Reperfusion Injury: Updated Mechanisms and Strategies.

Recent Advance on Drug Therapy Related to Myocardial Ischemia Reperfusion Injury

Characterization of Early Myocardial Inflammation in Ischemia-Reperfusion Injury

Modern Knowledge of Myocardial No-Reflow

A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023

MG53 Protein: A Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury

[Reperfusion Arrhythmias in Acute Myocardial Infarction Do Not Enhance Myocardial Injury].

Tumor Necrosis Factor-Α Inhibitor: A Promising Therapeutic Approach for Attenuating Myocardial Ischemia–reperfusion by Antioxidant Stress

A Bibliometric Study Related to the Treatment of Myocardial Ischemia-Reperfusion Injury

Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review)

Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury